Tag archive for ‘Migraine’
Alan Gallindoss On Sunday, July 14th, 2019

Israeli Breakthrough: An electric headband to eliminates migraines and depression

An Israeli startup Neurolief has developed a breaking through home treatment for migraine, depression as well as a range of neurological and neuropsychiatric disorders. The European Medicines Authority has approved More...

Jewish Business News On Sunday, December 30th, 2018

30 ways Israel inspired the world in 2018

Israeli conservationists crowdfund to save endangered species January 1 2018 Yellow-tailed woolly monkey is an endangered species The multinational This-is-My-Earth.org (TiME), led by Israeli conservation biologist More...

Jewish Business News On Sunday, September 16th, 2018

Teva Wins FDA Nod for Migraine Drug

Teva Pharmaceutical Industries today announced that the US Food and Drug Administration (FDA) has approved AJOVY (fremanezumab) injection for the preventive treatment of migraine in adults. The Israeli company’s More...

Alan Gallindoss On Monday, May 21st, 2018

Teva entered the FDA’s shame list

  The Food and Drug Administration (FDA) published the list of shame, which includes 40 pharmaceutical manufacturers trying to block generic drug competition. Among the companies are giants such as Novartis, More...

- On Monday, October 16th, 2017

FOR DIAGNOSED MIGRAINE SUFFERERS: Seeking additional volunteers to try a new natural treatment

  Seeking additional volunteers to try a new natural treatment for the relief of symptoms as simple as slurping on a sweet-tasting ice popsicle.  This is a free, private trial conducted under the guidance More...

Jewish Business News On Wednesday, July 15th, 2015

One World Cannabis to Offer New Alternative Treatment for Chronic Pain

– – One World Cannabis Ltd, a wholly owned subsidiary of Israel’s OWC Pharmaceutical Research Corp. (OTCQB: OWCP) which develops cannabinoid-based therapies targeting a variety of different indications, More...

Teva launches generic migraine treatment

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) has launched generic treatment is for migraine, Axert (almotriptan malate) tablets in 6.25 mg and 12.5 mg dosages, in the US. Teva is the first More...

ILLUSTRATION
Jewish Business News On Thursday, June 25th, 2015

children who suffer trauma from witnessing domestic violence or suffering sexual abuse are in Higher risk of migraine in later life

Adults who were exposed to childhood adversity, including witnessing parental domestic violence, childhood physical and sexual abuse have higher odds of experiencing migraine headaches in adulthood, according More...

Wordpress site Developed by Fixing WordPress Problems